NRG-BN001: Randomized Phase II Trial of Hypofractionated

Project: Research project

Project Details

Description

NRG-BN001: Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation with Concomitant and Adjuvant Temozolomide in Patients with New Diagnosed Glioblastoma
StatusFinished
Effective start/end date3/1/147/31/19

Funding

  • NRG ONCOLOGY FOUNDATION, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.